TNF-α and IL-6 can alter insulin sensitivity and stimulate the phosphorylation of serine residues instead of tyrosine in insulin receptor substrate-1 (IRS-1), thus inhibiting the activation of insulin signaling and sustaining insulin resistance. The gene discussed is INS; the disease is Insulin resistance.